At the 9.6 g dose, iSTEP-N provided sustained therapeutic naltrexone exposure for 12 weeks with a favorable safety profile, while releasing less than one-fourth of its drug content.
A Long-acting Naltrexone Implant (iSTEP-N) for Opioid Use Disorder